Abiopharma

News list

Mahadevia Ankit 🔴 sold 6.6K shares of Spero Therapeutics, Inc. (SPRO) at $1.97 Transaction Date: Aug 28, 2025 | Filing ID: 112661

Full text

News bot Sept. 3, 2025, 10:11 a.m.
🔍 Mahadevia Ankit (Executive)

Company: Spero Therapeutics, Inc. (SPRO)

Report Date: 2025-08-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,572
Detailed Transactions and Holdings:
- Sold 6,572 shares of Common Stock at $1.97 per share (Direct)
  Date: 2025-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 703,294.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
Footnotes:
- F1: The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock unit ("RSUs") that were granted to the Reporting Person on August 26, 2021.
- F2: Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.